This inventor holds 1 USPTO granted patent and 3 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Roche Diagnostics Operations, Inc.. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: The Innovative Contributions of Styliani Tournaviti
Introduction
Styliani Tournaviti is a notable inventor based in Munich, Germany. She has made significant contributions to the field of biotechnology, particularly in the production of antibodies. Her innovative work has implications for various medical applications, showcasing her expertise and dedication to advancing scientific knowledge.
Latest Patents
Tournaviti holds a patent titled "Method for producing antibodies using ovine B-cells and uses thereof." This patent describes a cultivation system for cultivating a pool of ovine B-cells or single deposited ovine B-cells in the presence of phorbol myristate acetate (PMA). This method represents a breakthrough in antibody production, potentially enhancing therapeutic options in medicine.
Career Highlights
Throughout her career, Tournaviti has worked with prominent companies in the biotechnology sector. She has been associated with Roche Diagnostics Operations, Inc. and F. Hoffmann-La Roche AG. Her experience in these organizations has allowed her to develop her skills and contribute to significant advancements in the field.
Collaborations
Tournaviti has collaborated with various professionals, including Mirko Ritter. These collaborations have fostered an environment of innovation and have led to the development of groundbreaking technologies in biotechnology.
Conclusion
Styliani Tournaviti's contributions to the field of biotechnology, particularly through her patent on antibody production, highlight her role as an influential inventor. Her work continues to inspire advancements in medical science and showcases the importance of innovation in addressing healthcare challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
